| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| HHLR ADVISORS, LTD. | 4.9% | -26% | $16,350,132,640 | -$5,784,964,646 | 68,551,141 | -26% | HHLR Advisors, Ltd. | 09 May 2025 |
As of 30 Sep 2025, 260 institutional investors reported holding 32,957,934 shares of BeOne Medicines Ltd. - Ordinary shares, par value $0.0001 per share (ONC). This represents 2.4% of the company’s total 1,385,160,313 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 27,407 | $8,364,228 | -$2,147,174 | $303.81 | 27 |
| 2025 Q3 | 32,957,934 | $11,225,971,347 | -$346,944,388 | $340.70 | 260 |
| 2025 Q2 | 34,445,503 | $8,338,029,358 | -$2,098,488,418 | $242.07 | 240 |
| 2025 Q1 | 42,522,880 | $11,571,290,738 | -$300,778,228 | $272.17 | 259 |
| 2024 Q4 | 43,643,682 | $8,061,061,147 | -$556,417,441 | $184.71 | 220 |
| 2024 Q3 | 46,387,065 | $10,410,403,172 | -$140,709,553 | $224.51 | 223 |
| 2024 Q2 | 46,778,251 | $6,675,796,297 | +$49,829,686 | $142.67 | 196 |
| 2024 Q1 | 46,405,233 | $7,257,217,531 | +$233,916,446 | $156.39 | 200 |
| 2023 Q4 | 34,825 | $6,269,949 | +$353,686 | $180.36 | 3 |
| 2023 Q3 | 46,821,398 | $8,423,244,830 | -$8,973,572 | $179.87 | 188 |
| 2023 Q2 | 46,934,709 | $8,368,914,130 | -$142,560,834 | $178.30 | 194 |
| 2023 Q1 | 47,668,673 | $10,275,560,122 | -$365,876,712 | $215.53 | 210 |
| 2022 Q4 | 49,303,290 | $10,847,763,148 | -$801,166,555 | $219.94 | 201 |
| 2022 Q3 | 53,443,095 | $7,207,039,667 | -$15,592,248 | $134.82 | 196 |
| 2022 Q2 | 53,401,007 | $8,643,775,994 | -$230,553,146 | $161.85 | 210 |
| 2022 Q1 | 54,891,500 | $10,363,536,114 | -$131,504,847 | $188.60 | 222 |
| 2021 Q4 | 51,627,354 | $13,983,601,276 | -$199,712,302 | $270.93 | 236 |
| 2021 Q3 | 55,983,215 | $20,320,686,326 | +$170,640,736 | $363.00 | 240 |
| 2021 Q2 | 55,460,687 | $19,037,292,751 | -$284,868,453 | $343.19 | 258 |
| 2021 Q1 | 56,480,778 | $19,491,865,606 | +$714,575,012 | $348.08 | 242 |
| 2020 Q4 | 53,149,942 | $13,730,791,993 | -$203,263,606 | $258.39 | 226 |
| 2020 Q3 | 54,801,174 | $15,693,904,741 | +$1,342,169,395 | $286.44 | 233 |
| 2020 Q2 | 49,117,793 | $9,252,708,810 | +$179,007,715 | $188.40 | 198 |
| 2020 Q1 | 48,375,764 | $5,955,755,286 | +$14,284,553 | $123.11 | 196 |
| 2019 Q4 | 48,835,643 | $8,094,439,533 | -$125,959,897 | $165.76 | 211 |
| 2019 Q3 | 49,554,837 | $6,068,202,908 | +$318,868,575 | $122.46 | 187 |
| 2019 Q2 | 48,664,075 | $6,031,826,336 | +$139,705,339 | $123.95 | 191 |
| 2019 Q1 | 46,581,872 | $6,147,792,912 | +$72,927,441 | $132.00 | 190 |
| 2018 Q4 | 47,308,130 | $6,634,397,750 | -$436,889,193 | $140.26 | 184 |
| 2018 Q3 | 45,412,987 | $7,821,189,762 | +$587,472,536 | $172.22 | 138 |
| 2018 Q2 | 42,021,663 | $6,460,034,864 | +$944,146,227 | $153.73 | 124 |
| 2018 Q1 | 36,228,256 | $6,086,285,344 | +$1,500,008,672 | $168.00 | 120 |
| 2017 Q4 | 27,567,001 | $2,693,889,000 | +$229,200,158 | $97.72 | 93 |
| 2017 Q3 | 25,042,053 | $2,590,841,144 | +$489,058,371 | $103.46 | 80 |
| 2017 Q2 | 20,398,866 | $917,947,000 | +$131,198,370 | $45.00 | 56 |
| 2017 Q1 | 17,607,585 | $644,614,000 | +$43,545,154 | $36.61 | 54 |
| 2016 Q4 | 16,604,419 | $504,116,000 | +$195,354,439 | $30.36 | 54 |
| 2016 Q3 | 10,161,007 | $313,122,000 | +$58,303,870 | $30.81 | 38 |
| 2016 Q2 | 8,275,571 | $241,300,000 | +$17,031,982 | $29.80 | 38 |
| 2016 Q1 | 7,506,105 | $219,924,000 | +$219,924,064 | $29.31 | 38 |